Lung cancer (non-small-cell) - cetuximab: final scope
Lung cancer (non-small-cell) - cetuximab: final matrix
Lung cancer (non-small-cell) - cetuximab: Institute's response to consultees and commentator comments on the draft scope and provisional matrix
Lung cancer (non-small-cell) - cetuximab: final scope (superseded)
Lung cancer (non-small-cell) - cetuximab: final matrix (superseded)
Lung cancer (non-small-cell) - cetuximab: Institute's response to consultee and commentator comments on the draft scope (superseded)
Lung cancer (non-small-cell) - cetuximab: Institute's response to consultee and commentator comments on the provisional matrix (superseded)
Lung cancer (non-small-cell) - cetuximab: email sent to consultees and commentators updating them on the status of this appraisal
Lung cancer (non-small-cell) - cetuximab: 9 March 2009, email sent to consultees and commentators regarding the delay to this appraisal
Lung cancer (non-small-cell) - cetuximab: final scope
Lung cancer (non-small-cell) - cetuximab: final matrix of consultees and commentators (superseded)
Lung cancer (non-small-cell) - cetuximab: comments on the draft scope
Lung cancer (non-small-cell) - cetuximab: draft scope
Lung cancer (non-small-cell) - cetuximab: comments on the draft matrix
Lung cancer (non-small-cell) - cetuximab: draft matrix of consultees and commentators